IL-33/ST2 Signaling in the Pathogenesis of Chronic Pain and Itch

Neuroscience. 2023 Oct 1:529:16-22. doi: 10.1016/j.neuroscience.2023.08.013. Epub 2023 Aug 11.

Abstract

Interleukin-33 (IL-33) is an inflammatory factor with an extensive range of biological effects and pleiotropic roles in diseases. Evidence suggests that IL-33 and its receptor ST2 play a pivotal role in chronic pain and itch at the level of primary sensory neurons, the spinal cord, and the brain. In this review, we outline an evolving understanding of the roles and mechanisms of IL-33 in chronic pathological pain, including inflammatory, neuropathic, and cancer, and chronic pruritus, such as allergic contact dermatitis, atopic dermatitis, and dry skin. Understanding the key roles of IL-33/ST2 signaling may provide exciting insights into the mechanisms of chronic pain and itch and lead to new clues for therapeutic approaches to the resolution of chronic pain and itch.

Keywords: ST2; chronic pain; chronic pruritus; interleukin-33.

Publication types

  • Review